Islam A B Azharul, Bishara Samuel, Charitopoulos Konstantinos, Ellis David, Nikolinakos Panagiotis, Poushi Maisha Zaman, Donkov Ivo
Urology, West Middlesex University Hospital, London, GBR.
Surgery, Dhaka Medical College and Hospital, Dhaka, BGD.
Cureus. 2025 Apr 9;17(4):e81968. doi: 10.7759/cureus.81968. eCollection 2025 Apr.
Renal angiomyolipoma (AML) is a benign mesenchymal tumor that is often treated with transcatheter arterial embolization (TAE) to prevent complications such as hemorrhage. Although TAE is generally effective, it can lead to complications, including renal ischemia and atrophy. We present the case of a 72-year-old woman who underwent embolization for a right renal AML. After the procedure, she experienced damage to the renal artery, which resulted in progressive kidney shrinkage and impaired renal function. This case highlights the potential complications of embolization in managing renal AML and highlights the necessity for the long-term monitoring of renal function after the procedure.
肾血管平滑肌脂肪瘤(AML)是一种良性间叶组织肿瘤,常采用经导管动脉栓塞术(TAE)治疗以预防出血等并发症。尽管TAE通常有效,但它可能导致包括肾缺血和萎缩在内的并发症。我们报告一例72岁女性因右侧肾AML接受栓塞治疗的病例。术后,她出现肾动脉损伤,导致肾脏逐渐萎缩和肾功能受损。该病例突出了栓塞治疗肾AML的潜在并发症,并强调了术后长期监测肾功能的必要性。